-

Shareholder Alert: Robbins LLP is Investigating OneSpan Inc. (OSPN) for Shareholders

SAN DIEGO & CHICAGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating OneSpan Inc. (NASDAQ: OSPN) to determine whether certain OneSpan officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. OneSpan and its subsidiaries design, develop, and market solutions for identity, security, and business productivity.

If you suffered a loss due to OneSpan Inc.'s misconduct, click here.

OneSpan Inc. (OSPN) Overstated its Revenue

OneSpan Inc. may have made false and misleading statements regarding the Company's internal policies and downplayed the likely negative impact on its profits. On August 4, 2020, OneSpan postponed its second quarter 2020 earnings release due to revenue recognition problems spanning from the first quarter of 2018 through the first quarter of 2020, "which caused overstatements of revenue." After market close on August 11, 2020, the Company announced that it would not be able to timely submit its SEC report for the quarter ending on June 30, 2020, that same quarter year-over-year revenues had declined, and withdrew its full year 2020 earnings guidance, which it had just confirmed one quarter earlier. On this news, the Company stock price fell almost 40% to close at $18.84 per share on August 12, 2020.

OneSpan Inc. (OSPN) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against OneSpan Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Ardelyx, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc. develops and commercializes medicines, including ISBRELA for the treatment of irritable bowel syndrome with constipation and XPHOZAH for reducing serum phosphorus in adults with chr...

Investor Notice: Robbins LLP Informs Investors of the AppLovin Corporation Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired AppLovin Corporation (NASDAQ: APP) securities between February 12, 2026 and August 5, 2026, inclusive (the Class Period). AppLovin provides end-to-end artificial intelligence- (“AI”) powered advertising solutions for businesses to reach, monetize and grow their global audience.The complaint alleges that AppLovin...

GUTS Stockholders Have Rights – If you Lost Money Investing in Fractyl Health, Inc. Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity. The complaint alleges that Fractyl Health misled investors regarding...
Back to Newsroom